Belimumab Maintenance Fails to Delay Relapse in AAV Patients, Phase 3 Trial Suggests – ANCA Vasculitis News

Belimumab Maintenance Fails to Delay Relapse in AAV Patients, Phase 3 Trial Suggests – ANCA Vasculitis News

Belimumab Maintenance Fails to Delay Relapse in AAV Patients, Phase 3 Trial Suggests – ANCA Vasculitis News
Published on 2019-02-04